Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-300
Closed -$1.52K 15309
2025
Q1
$1.52K Sell
300
-400
-57% -$2.27K ﹤0.01% 14123
2024
Q4
$4.12K Sell
700
-1,400
-67% -$9.18K ﹤0.01% 13950
2024
Q3
$15.6K Buy
2,100
+400
+24% +$2.78K ﹤0.01% 12960
2024
Q2
$12.3K Buy
1,700
+1,400
+467% +$10.1K ﹤0.01% 12989
2024
Q1
$2.45K Buy
300
+100
+50% +$801 ﹤0.01% 14006
2023
Q4
$1.38K Sell
200
-4,800
-96% -$29.3K ﹤0.01% 13836
2023
Q3
$25.1K Buy
5,000
+900
+22% +$4.81K ﹤0.01% 12434
2023
Q2
$19.7K Buy
4,100
+1,400
+52% +$5.56K ﹤0.01% 12739
2023
Q1
$10.4K Buy
2,700
+1,800
+200% +$7.33K ﹤0.01% 13538
2022
Q4
$3.38K Buy
+900
New +$3.44K ﹤0.01% 14221

Other funds holding VTEX

Citadel Advisors's VTEX Position: Q2 2026 in Review

Citadel Advisors increased its VTEX (VTEX) stake by 223% in Q2 2026, buying an estimated $3.68M and bringing the position to 1,397,368 shares worth $5.59M. The position accounts for ﹤0.01% of the portfolio, ranked #4526.

Citadel Advisors first reported a position in VTEX in Q3 2021 and has held it in 20 quarters since. 109 funds tracked by Wall St. Rank hold VTEX as of Q2 2026.

  • Citadel Advisors held 1,397,368 shares of VTEX worth $5.59M as of Q2 2026.
  • Citadel Advisors bought 964,682 VTEX shares in Q2 2026, an estimated $3.68M.
  • VTEX made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #4526 holding.
  • Citadel Advisors first reported a position in VTEX in Q3 2021 and has held it in 20 quarters since.
  • 109 funds tracked by Wall St. Rank held VTEX as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.